Evidence map›Paper›PMID 28423675›Full record

ArticleOncotarget2017

miR-219-5p targets CaMKIIγ to attenuate morphine tolerance in rats.

Jian Wang, Wei Xu, Jiali Shao, Zhenghua He, Zhuofeng Ding, Jiangju Huang, Qulian Guo, Wangyuan Zou

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Epigenetics of Drug Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  6. Roles of N-Methyl-D-Aspartate Receptors (NMDARs) in Epilepsy.Frontiers in molecular neuroscience · 2021
    Review
  7. Review
  8. Protein Translation and Psychiatric Disorders.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2020
    Review
  9. Functional Analysis of the 3' Untranslated Region of the HumanNeuropsychiatric disease and treatment · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jian WangDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Wei XuDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Jiali ShaoDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Zhenghua HeDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Zhuofeng DingDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Jiangju HuangDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Qulian GuoDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Wangyuan ZouDepartment of Anesthesiology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Morphine tolerance is a clinical challenge in pain management. Emerging evidence suggests that microRNA (miRNA) plays a regulatory role in the development of morphine tolerance. miR-219-5p (miR-219) targets calmodulin-dependent protein kinase II γ (CaMKIIγ) to activate central pain sensitization via N-methyl-D-aspartate (NMDA) receptor. Therefore, we hypothesized that miR-219-5p attenuates morphine tolerance by targeting CaMKIIγ. We found that the expression of miR-219-5p was decreased significantly after chronic morphine treatment. Overexpression of miR-219-5p by lentivirus injection prevents the development of morphine tolerance. CaMKIIγ, the target gene of miR-219-5p was downregulated by overexpression of miR-219-5p both in vivo and in vitro. Furthermore, we found that lentiviral-mediated miR-219-5p decreased the expression of NMDA receptor subunit 1 (NR1), leading to attenuation of morphine tolerance. Overall, the data demonstrate that miR-219-5p plays a crucial role in alleviating morphine tolerance by inhibiting the CaMKII/NMDA receptor pathway. Overexpression of miR-219-5p may be a potential strategy to ameliorate morphine tolerance.

Indexed as

RNA InterferenceAnalgesics, OpioidAnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2Cell LineDown-RegulationDrug ToleranceGene ExpressionMaleMicroRNAsMorphinePharmacogeneticsRatsReceptors, N-Methyl-D-AspartateSpinal CordAnalgesics, OpioidCalcium-Calmodulin-Dependent Protein Kinase Type 2MicroRNAsMIRN219 microRNA, ratMorphineReceptors, N-Methyl-D-AspartateCaMKIIγmicroRNAmorphine toleranceNMDA

Identifiers

PMID28423675
PMCPMC5438643
OpenAlexW2594605948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.